-
¹ØÓÚÈËÉú¾ÍÊDz«¹ÙÍø
-
Á¢ÒìÓë¹ú¼Ê»¯
-
ÈËÉú¾ÍÊDz«¹ÙÍø¶¯Ì¬
-
-
¿ÉÒ»Á¬Éú³¤
-
-
-
У԰ÕÐƸ
-
ʵϰÉúÕÐƸ
-
ÍâÑóÈ˲ÅÕÐƸ
¼ÓÈëÎÒÃÇ
-
-
ÆóÒµÉú³¤¶¯Ì¬×îÇ°ÑØ£¬£¬£¬ £¬£¬ºëÑïÈËÉú¾ÍÊDz«¹ÙÍøÕýÄÜÁ¿
·ï»ËÍøعú²úÐÂÒ»´úALKÒÖÖƼÁ¡ª¡ªÈËÉú¾ÍÊDz«¹ÙÍøÖÆÒ©ÒÁ³°¢¿ËÁÙ´²Êý¾Ý¹ú¼ÊÊ×´ÎÐû²¼
ABOUT US
·ï»ËÍøعú²úÐÂÒ»´úALKÒÖÖƼÁ¡ª¡ªÈËÉú¾ÍÊDz«¹ÙÍøÖÆÒ©ÒÁ³°¢¿ËÁÙ´²Êý¾Ý¹ú¼ÊÊ×´ÎÐû²¼
Ðû²¼Ê±¼ä£º
2022-02-26
¿ËÈÕ£¬£¬£¬ £¬£¬ÓÉÖøÃû·Î°©×¨¼Ò¡¢Öйúҽѧ¿ÆѧԺÖ×ÁöҽԺʯԶ¿½ÌÊÚÖ÷µ¼µÄ¹ú²úÁ¢ÒìÒ©ÎïÒÁ³°¢¿ËIÆÚÁÙ´²Ñо¿Ð§¹ûSafety and activity of WX-0593 (Iruplinalkib) in patients with ALK- or ROS1-rearranged advanced non-small cell lung cancer: a phase 1 dose-escalation and dose-expansion trial ÕýʽÔÚÆÚ¿¯Signal Transduction and Targeted Therapy£¨¡¶ÐźÅתµ¼ºÍ°ÐÏòÖÎÁÆ¡·£©È«ÎĽÒÏþ¡£¡£¡£¡£¡£
ÒÁ³°¢¿ËƬÊÇÓÉÈËÉú¾ÍÊDz«¹ÙÍøÖÆÒ©×ÔÖ÷Ñз¢µÄÐÂÐÍALK/ROS1ÒÖÖƼÁ£¬£¬£¬ £¬£¬¿ÉÒÖÖƲî±ðÈÚºÏÀàÐ͵ÄÒ°ÉúÐÍÒÔ¼°ALKÒÖÖƼÁÄÍÒ©Í»±äµÄALK¼¤Ã¸»îÐÔ£¬£¬£¬ £¬£¬Í¬Ê±¿ÉÓÐÓÃÒÖÖƲî±ðÈÚºÏÀàÐÍROS1¼¤Ã¸µÄ»îÐÔ¡£¡£¡£¡£¡£
ÎÄÕÂϵͳÏÈÈÝÁËÒÁ³°¢¿ËÔÚ¢ñÆÚ¼ÁÁ¿µÝÔö¼°ÈËȺÀ©Õ¹½×¶ÎÖÐÇå¾²ÐÔ¡¢ÄÍÊÜÐÔ¼°ÆðÔ´ÁÆЧµÈµÄÖÜÈ«ÆÊÎö¡£¡£¡£¡£¡£¼ÁÁ¿µÝÔö½×¶ÎµÄÖ÷ÒªÖÕµãÖ¸±êΪ×î´óÄÍÊܼÁÁ¿£¨MTD£©£¬£¬£¬ £¬£¬¼ÁÁ¿ÏÞÖÆÐÔ¶¾ÐÔ£¨DLT£©ºÍÇå¾²ÐÔ£¬£¬£¬ £¬£¬ÈËȺÀ©Õ¹½×¶ÎµÄÖ÷ÒªÖÕµãÖ¸±êΪÑо¿ÕßÆÀ¹ÀµÄ¿Í¹Û»º½âÂÊ£¨ORR£©¡£¡£¡£¡£¡£×Ô2017Äê9ÔÂ25ÈÕÖÁ2018Äê10ÔÂ15ÈÕ£¬£¬£¬ £¬£¬µÝÔö½×¶Î¹²Èë×é54ÀýALK/ROS1+ NSCLC»¼Õߣ¬£¬£¬ £¬£¬À©Õ¹½×¶Î¹²Èë×é99ÀýALK/ROS1+ NSCLC»¼Õߣ¬£¬£¬ £¬£¬¹²¼Æ153Àý»¼Õß½ÓÊÜÁËÒÁ³°¢¿ËƬÖÎÁÆ£¬£¬£¬ £¬£¬±¾Ñо¿Î´»ñµÃMTD¡£¡£¡£¡£¡£µÝÔö½×¶ÎºÍÀ©Õ¹½×¶ÎµÄÕûÌåORR»®·ÖΪ59.3% (32/54)ºÍ56.6% (56/99)¡£¡£¡£¡£¡£ÆäÖУ¬£¬£¬ £¬£¬Î´½ÓÊܹýALKÒÖÖƼÁÖÎÁƵÄALK+NSCLC»¼ÕßÖУ¬£¬£¬ £¬£¬Á½½×¶ÎµÄORR»®·ÖΪ81.0% (17/21) ºÍ76.3% (29/38)£» £» £»£»£» £»¼ÈÍù½ÓÊܹý¿ËßòÌæÄáÖÎÁƵÄALK+NSCLC»¼ÕßÖУ¬£¬£¬ £¬£¬Á½½×¶ÎµÄORR»®·ÖΪ38.1% (8/21) ºÍ 45.7% (21/46)¡£¡£¡£¡£¡£ÔÚROS1+NSCLC»¼ÕßÖУ¬£¬£¬ £¬£¬µÝÔöºÍÀ©Õ¹½×¶ÎµÄORR»®·ÖΪ30.0% (3/10)ºÍ44.4% (4/9)¡£¡£¡£¡£¡£ÒÔÉÏÊý¾ÝÏÔʾ£¬£¬£¬ £¬£¬ÒÁ³°¢¿ËÔÚALK/ROS1+ NSCLC»¼ÕßÖоßÓÐÓÅÒìµÄÇå¾²ÐÔ¡¢ÄÍÊÜÐԺͿ¹Ö×Áö»îÐÔ¡£¡£¡£¡£¡££¨µÝÔöºÍÀ©Õ¹½×¶ÎÖл¼ÕßÖ×ÁöÏà¶Ô»ùÏßת±äµÄ×î´ó°Ù·Ö±È¼ûͼaºÍͼb£©
·Î°©ÊÇÏÖÔÚÈ«Çò×î³£¼ûµÄ¶ñÐÔÖ×Áö£¬£¬£¬ £¬£¬Ò²ÊǶñÐÔÖ×ÁöéæÃüµÄÊ×λԵ¹ÊÔÓÉ£¬£¬£¬ £¬£¬Ô¼Õ¼ËùÓжñÐÔÖ×ÁöéæÃüµÄ18%¡£¡£¡£¡£¡£ÎÒ¹ú·Î°©µÄ·¢²¡Âʼ°éæÃüÂÊÔöÌíѸËÙ£¬£¬£¬ £¬£¬ÒѳÉΪÎÒ¹ú¶ñÐÔÖ×Áö·¢²¡ºÍéæÃüµÄÊ×λԵ¹ÊÔÓÉ¡£¡£¡£¡£¡£·ÇСϸ°û·Î°©£¨NSCLC£©ÊǷΰ©ÖÐ×î³£¼ûµÄ²¡Àí×é֯ѧÀàÐÍ£¬£¬£¬ £¬£¬Ô¼Õ¼·Î°©µÄ85£¥£¬£¬£¬ £¬£¬ÆäÔçÆÚÕï¶ÏÄÑ»¼ÕßÔ¤ºó²î£¬£¬£¬ £¬£¬ÍùÍùÒ»¾È·Õï¾ÍÒѾ´¦ÓÚÍíÆÚ£¬£¬£¬ £¬£¬ÊǷΰ©»¼ÕßÖÂËÀÂʸߵÄÖ÷ÒªÔµ¹ÊÔÓÉ¡£¡£¡£¡£¡£
½üÄêÀ´£¬£¬£¬ £¬£¬ÍíÆÚ·ÇСϸ°û·Î°©ÔÚÖÎÁÆ·½Ãæ·ºÆðÖØ´óµÄģʽת±ä¡£¡£¡£¡£¡£Òªº¦Ö°©ÐÔÍ»±ä£¨ÈçÇý¶¯»ùÒòÍ»±äºÍȾɫÌåÖØÅÅ£©µÄ·¢Ã÷£¬£¬£¬ £¬£¬Ê¹µÃ°ÐÏòÖÎÁÆÏà±È¹Å°åµÄϸ°û¶¾ÐÔ»¯Ñ§ÁÆ·¨ÏÔʾ³ö¸ü¸ßµÄÃô¸ÐÐÔ¡£¡£¡£¡£¡£¼ä±äÐÔÁÜ°ÍÁö¼¤Ã¸£¨ALK£©»ùÒòÍ»±äÓÉÓÚ±¬·¢Âʵͣ¬£¬£¬ £¬£¬µ«¶Ô°ÐÏòÖÎÁÆÃô¸ÐÐԺ㬣¬£¬ £¬£¬ÉúÑÄʱ¼ä³¤±»³ÆΪ·Î°©µÄ“×êʯͻ±ä”¡£¡£¡£¡£¡£¿£¿£¿£¿£¿£¿ £¿ËßòÌæÄáÊǵÚÒ»´úÕë¶ÔALK+NSCLCµÄ°ÐÏòÒ©ÎALK-TKI£©£¬£¬£¬ £¬£¬Ö»¹Ü»¼Õ߶ԿËßòÌæÄáµÄÖÎÁÆÓÐÓÅÒìµÄ·´Ó¦£¬£¬£¬ £¬£¬µ«´ó´ó¶¼»¼Õß×îÖջᱬ·¢ÄÍÒ©£¬£¬£¬ £¬£¬°üÀ¨Ô·¢ÄÍÒ©ºÍ¼Ì·¢ÄÍÒ©£¬£¬£¬ £¬£¬²¢ÇÒ¿ËßòÌæÄá¶ÔºÏ²¢ÄÔתÒÆÕßµÄÁÆЧ²»¾¡ÈçÈËÒâ¡£¡£¡£¡£¡£°¢À´ÌæÄá×÷ΪµÚ¶þ´úALK-TKIµÄ´ú±íËäÈ»±»Ö¤Êµ¾ßÓи߶ÈÑ¡ÔñÐÔºÍÂÄÚ²¡Ôî¿ØÖÆÂÊ£¬£¬£¬ £¬£¬µ«ÏÕЩËùÓеĻ¼ÕßÒ²»áÔÙ´ÎÏ£ÍûΪTKIÄÍÒ©£¬£¬£¬ £¬£¬Òò´ËALK+NSCLC»¼ÕßÈÔÈ»±£´æ½Ï´óδ±»Öª×ãµÄÖÎÁÆÐèÇ󡣡£¡£¡£¡£
ÕýÊÇÔÚÕâÒ»Åä¾°Ï£¬£¬£¬ £¬£¬ÈËÉú¾ÍÊDz«¹ÙÍøÖÆÒ©Æ𾢽ṹ£¬£¬£¬ £¬£¬ÊµÑéÁËÒ»ÀàÁ¢ÒìÒ©ÎïÒÁ³°¢¿ËÑз¢ÏîÄ¿¡£¡£¡£¡£¡£ÓÚ2016Äê5ÔÂÊ×´ÎÉ걨ÁÙ´²£¬£¬£¬ £¬£¬2017Äê10ÔÂÊ״ι«Ê¾Æô¶¯ÁÙ´²£¬£¬£¬ £¬£¬NDAÒÑÓÚ2021Äê7ÔÂÌá½»ÖÁCDE²¢»ñµÃÊÜÀí¡£¡£¡£¡£¡£
¾ÝϤ£¬£¬£¬ £¬£¬ÈËÉú¾ÍÊDz«¹ÙÍøÖÆÒ©±¾´ÎÉêÇëÉÏÊеÄ˳Ӧ֢Ϊ“ÊÊÓÃÓÚ¼ÈÍù½ÓÊܹý¿ËßòÌæÄáÖÎÁƺ󼲲¡Ï£Íû»ò¶Ô¿ËßòÌæÄá²»ÄÍÊܵļä±äÐÔÁÜ°ÍÁö¼¤Ã¸£¨ALK£©ÑôÐԵľֲ¿ÍíÆÚ»òתÒÆÐÔ·ÇСϸ°û·Î°©£¨NSCLC£©»¼ÕßµÄÖÎÁÆ”£¬£¬£¬ £¬£¬Êý¾ÝȪԴÓÚÒ»Ïîµ¥±Û¡¢¢òÆÚÁÙ´²Ñо¿¡£¡£¡£¡£¡£
²úÆ·ÓÐÍûÓÚ½ñÄêÏ°ëÄêÔÚº£ÄÚÉÏÊУ¬£¬£¬ £¬£¬ÎªÖйúÍíÆÚALKÑôÐÔ·ÇСϸ°û·Î°©»¼ÕßÌṩеÄÖÎÁÆÑ¡Ôñ¡£¡£¡£¡£¡£
Ïà¹ØÐÂÎÅ
0531-83126666 
wangzhan@qilu-pharma.com 
µç»°£º0531-83126666 / 7777 / 8888 / 9999
Ò©Îﾯ½ä¿Í·þÈÈÏߣº400-127-7799
´«Õ棺0531-83126688 / 9688
µØµã£ºÉ½¶«Ê¡¼ÃÄÏÊиßÐÂÇøÂÃÓη8888ºÅ
ÓÊÏ䣺wangzhan@qilu-pharma.com
¹©Ó¦É̹ÜÀíÖ°Ô±
Éú²úÀ๩ӦÉ̹ÜÀí
Àî¡¡»¢ 0531-83126624
ÕÅê»î£ 0531-55820677
ÐÏ¡¡Ó¯ 0531-55820612
¾®Î¬ÖÞ 0531-55820837
·ÇÉú²úÀ๩ӦÉ̹ÜÀí
Õźé·å 0531-83129021
Ì·ºìÑÒ 0531-83129023
Ñз¢À๩ӦÉ̹ÜÀí
Àî½ð»¨ 0531-55820602
ÀîÕñ½ 0531-55820848
·þÎñÀ๩ӦÉ̹ÜÀí
·½¡¡Á¢ 0531-55820861
ÕÔ²ý¹ó 0531-55820857
¼àÊÓ¾Ù±¨
Ç×°®µÄÏàÖúͬ°é£º
½Ó´ý¾Ù±¨ÒÔÏÂÐÐΪ£¡
Ë÷»ß¡¢°µÏäʹÓÃÕбꡢÄÚ¶¨Öб굥λ¡¢Ô±¹¤»òÖ§Êô¼ÓÈ빫˾ӪҵÍùÀ´Ä²È¡Ë½Àû¡¢Íµ¹¤¼õÁÏ¡¢ÒԴγäºÃ¡¢¾ÓÐĵóÄѹ©Ó¦É̵ÈÐÐΪ¡£¡£¡£¡£¡£
¾Ù±¨µç»°£º0531-83126898/55820713/83126871
¾Ù±¨ÓÊÏ䣺qljc@qilu-pharma.com
ÊÕÐŵص㣺ɽ¶«Ê¡¼ÃÄÏÊÐÀú³ÇÇøÂÃÓη8888ºÅ
ÈËÉú¾ÍÊDz«¹ÙÍøÖÆÒ©¼¯ÍÅÉó¼Æ¼à²ì²¿
²É¹ºÆ½Ì¨ÊÖÒÕרÏß